Fundraising Fox

Shaun A. Kirkpatrick

Investor

President, Biotechnologies at Research Corporation Technologies

Tucson

About

Kirkpatrick has over 25 years of experience managing venture investments and technology development programs across oncology, inflammation, metabolic disease, neurological disorders, and biotherapeutics and life science tools. He oversees RCT's venture investments, technology development, and special licensing programs, and serves on several biomedical startup boards, including as a founding director of the Critical Path Institute.

Contact· self-published, not guessed

Invests in

BiotechHealthtechMedical Devices

Experience

  1. Research Corporation Technologies, Inc.President & Board Membercurrent2004 — presentTucson, Arizona, United States
  2. Research Corporation Technologies, Inc.Vice President2001 — 2003Tucson, Arizona, United States
  3. Research Corporation Technologies, Inc.Director1999 — 2000Tucson, Arizona, United States
  4. Research Corporation Technologies, Inc.Associate1993 — 1998Tucson, Arizona, United States
  5. AustinPx, Pharmaceutics and ManufacturingChairmancurrent2014 — presentAustin, Texas Metropolitan Area
  6. Translational Drug Development (TD2)Chairmancurrent2020 — presentScottsdale, Arizona, United States
  7. Pheon TherapeuticsBoard Membercurrent2015 — presentLondon Area, United Kingdom
  8. Particle DynamicsBoard Membercurrent2021 — presentSt. Louis City County, Missouri, United States
  9. Critical Path Institute (C-Path)Board Membercurrent2005 — presentTucson, Arizona, United States
  10. Flinn FoundationBoard Membercurrent2008 — presentPhoenix, Arizona, United States
  11. Thomas R. Brown FoundationsBoard Membercurrent2015 — presentTucson, Arizona, United States
  12. Cylene PharmaceuticalsBoard Member2005 — 2010San Diego County, California, United States
  13. APT PharmaceuticalsBoard Member2005 — 2007Burlingame, California, United States
  14. Alimmune, LLCBoard Member2001 — 2007Tucson, Arizona, United States
  15. Therapeutic Human Polyclonals, Inc.Chairman2000 — 2007Sunnyvale, California, United States

Investments

Board seats

Alimmune LLCAPT Pharmaceuticals Inc.AustinPx™, LLCCodis™Cylene Pharmaceuticals Inc.Imagine Pharmaceuticals Inc.Pheon TherapeuticsProlifia Inc.Sertoli Technologies, Inc.Therapeutic Human Polyclonals Inc.Translational Drug Development, LLC

Per the firm's website.

Colleagues at Research Corporation Technologies

Avi Roop
Managing Director at Research Corporation Technologies
Brad Morie
Senior Director, Biotechnologies at Research Corporation Technologies
Chad W. Souvignier
Vice President at Research Corporation Technologies
Christopher P. Martin
President, Medical Devices and CFO at Research Corporation Technologies
Danielle Wilson
Director of Administration & Corporate Secretary at Research Corporation Technologies
David A. Wiersma
Senior Associate at Research Corporation Technologies
Jorge Figueroa
Systems Administrator at Research Corporation Technologies
Kathleen M. Hunter-Gregory
Controller at Research Corporation Technologies

Frequently asked questions

Who is Shaun A. Kirkpatrick?
Kirkpatrick has over 25 years of experience managing venture investments and technology development programs across oncology, inflammation, metabolic disease, neurological disorders, and biotherapeutics and life science tools. He oversees RCT's venture investments, technology development, and special licensing programs, and serves on several biomedical startup boards, including as a founding director of the Critical Path Institute.
Where does Shaun A. Kirkpatrick work?
Shaun A. Kirkpatrick is President, Biotechnologies at Research Corporation Technologies.
What does Shaun A. Kirkpatrick invest in?
Shaun A. Kirkpatrick invests in Biotech, Healthtech, Medical Devices.
What boards does Shaun A. Kirkpatrick sit on?
Shaun A. Kirkpatrick holds tracked board seats at Alimmune LLC, APT Pharmaceuticals Inc., AustinPx™, LLC, Codis™, Cylene Pharmaceuticals Inc., Imagine Pharmaceuticals Inc., Pheon Therapeutics, Prolifia Inc., Sertoli Technologies, Inc., Therapeutic Human Polyclonals Inc..
Where did Shaun A. Kirkpatrick go to school?
Shaun A. Kirkpatrick studied at Johns Hopkins School of Advanced International Studies (SAIS) (Master's degree, International Economics and and Science/Technology in International Relations); University of Arizona (Bachelor's degree, Biology and Economics).

Same school

Also attended Johns Hopkins School of Advanced International Studies (SAIS)63

Jessica (Bartos) ThomasPartner at Notion CapitalStephanie KomsaVice President – Institutional Client Relations, ATEL Capital Group at ATEL VenturesKayla RenzChief of Staff at First Row PartnersAshley N. PattonSr. Stewardship Analyst at Sands Capital VenturesJanna AyoubChief of Staff at C5 CapitalChristian SiegeleManaging Partner at Capnamic

+ 57 more

Also attended University of Arizona137

Benjamin BrockwellVenture Partner at Copper Sky CapitalMary PattonScientific Advisory Board at InnoCom Bio EquitiesTom KalinskeInvestor at Alsop Louie PartnersEmily FritzePartner at The Westly GroupPhil WickhamExecutive Managing Director at Sozo VenturesLaura SageDirector, Marketing & Investor Relations at Windham Capital Partners

+ 131 more

Shared employers

Also worked at Translational Drug Development (TD2)1

Laurie HeilmannVenture Partner at Propel Bio Partners

Also worked at APT Pharmaceuticals1

Corey van der WalFounder at Frame